GOLETA, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ: ALMU) (“Aeluma” or the “Company”), a transformative semiconductor company specializing in high-performance and scalable technologies, today reported financial results for its first quarter of fiscal 2026 ended September 30, 2025.

Management Commentary

“We had another strong quarter executing on our strategic priorities including bolstering our balance sheet with a capital raise to accelerate growth, adding key talent throughout the organization, increasing our manufacturing readiness, and advancing towards commercialization,” said Jonathan Klamkin, Ph.D., Founder and CEO of Aeluma. “In this quarter, we also initiated a new contract with NASA, met several milestones for existing contracts, and made continued progress on customer engagements. The rapid acceleration of AI is driving unprecedented demand for optical component technologies, and we are uncovering greater opportunity aligned with our offerings and product roadmap. As we progress in fiscal 2026 with a solid financial position and positive trends in our target market verticals, our focus is on executing our go-to-market strategy to drive long-term shareholder value.”

Recent Company Highlights

  • Strong Financial Position: Closed fiscal Q1 2026 with $38 million in cash and no long-term debt.
  • New Contract with NASA: Executed one new R&D contract related to quantum. New contract to leverage Aeluma’s scalable semiconductor platform to provide a path to low size, weight and power quantum systems for space applications.
  • Increased Manufacturing Readiness: Increased outsourced wafer fabrication activities nearly five-fold. Acquired key equipment assets to increase in-house test and validation capacity for qualifying outsourced wafer production processes.
  • New Hires: Attracted highly experienced and accomplished professionals to fill key manufacturing and engineering positions including Director of Supply Chain Manufacturing and Director of Technology Enablement.
  • Intellectual Property: Recently filed two nonprovisional patent applications for core innovations. One relates to scalable, large-diameter wafer manufacturing for photonic components, and the other to large-format imaging sensors. Brings total issued and pending patents to 34.

Fiscal Q1 2026 Financial Results

  • Revenue was $1.4 million compared to $481 thousand in the first quarter of 2024, and $1.3 million in the fourth quarter of 2025. Revenue in the quarter was primarily from R&D contracts.
  • GAAP net loss was $1.5 million, or ($0.09) per basic and diluted share, compared to a net loss of $730 thousand, or ($0.06) per basic and diluted share, for the same period last year and net loss of $859 thousand, or ($0.05) per basic and diluted share, in the prior quarter.
  • GAAP net loss increased from the prior quarter primarily due to higher salaries, stock-based compensation and employee benefits driven by new employees hires to support the expansion of the business and scaling of operations.
  • Adjusted EBITDA loss was $450 thousand, compared to a loss of $457 thousand in the same period last year, and a loss of $113 thousand in the prior quarter.
  • Cash and cash equivalents totaled $38.1 million at September 30, 2025, compared to $15.7 million as of June 30, 2025.

Fiscal Year 2026 Guidance and Strategic Priorities

For the full fiscal year of 2026, based on current and anticipated market conditions, Aeluma continues to expect revenue in a range of $4.0 million to $6.0 million. The Company’s strategic priorities for 2026 include:

  • New Contract Wins: Three to seven new development contracts, which provide non-dilutive funding for R&D investments and the growth of partnership opportunities.
  • Team Expansion: Growth of our business development and go-to-market team, technical leadership and staff, and operations team.
  • Enhanced Manufacturing Readiness: Higher levels of outsourced wafer manufacturing productivity, expanded test and validation capabilities, technology qualification for targeted industries, and expanded supply chain partnerships.
  • Go-to-Market Traction: Continued progress on opportunities in target commercial markets and increasing the number of customer engagements in the pipeline. Immediate near-term focus on defense and aerospace, and photonics for AI infrastructure driving our product roadmap.

Conference Call and Webcast

Aeluma will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on November 12, 2025, to discuss the Company’s financial results and business outlook. Interested participants may access the conference the call by dialing (877) 317-6789 (domestic) or (412) 317-6789 (international) and referencing “Aeluma.”

A live webcast of the call will be available on the “Investors” section of Aeluma’s website and can also be accessed by clicking here . A replay of the conference call will be available on Aeluma’s website shortly after the call concludes.

Note about Non - GAAP Financial Measures

This press release includes and makes reference to certain non-GAAP financial measures. The presentation of this financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Aeluma believes that the presentation of non-GAAP financial measures provides important supplemental information to management and investors regarding financial and business trends relating to the Company's financial condition and results of operations. Aeluma believes that these non-GAAP financial measures provide additional insight into Aeluma's ongoing performance and core operational activities and has chosen to provide these measures for more consistent and meaningful comparison between periods. These measures should only be used to evaluate Aeluma's results of operations in conjunction with the corresponding GAAP measures. The non-GAAP results exclude the effect of stock-based compensation, depreciation and amortization.

This press release includes non-GAAP financial measures, including:

  • Non-GAAP net income (loss), which is defined as GAAP net income (loss) plus stock-based compensation expenses, amortization of discount on convertible notes, and changes in fair value of derivative liabilities; and
  • Adjusted EBITDA, defined as non-GAAP net income (loss) plus depreciation and amortization expenses, less interest income.

A reconciliation between GAAP and non-GAAP financial results is provided in the financial statements portion of this press release.

Forward-Looking Statements

All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to the Company's expectations regarding its market position and market opportunity, expectations and plans as to its product development, manufacturing and sales, and relations with its partners and investors. These statements are not historical facts but rather are based on the Company's current expectations, estimates, and projections regarding its business, operations and other similar or related factors. Words such as “may,” “will,” “could,” “would,” “should,” “anticipate,” “predict,” “potential,” “continue,” “expect,” “intend,” “plan,” “project,” “believe,” “estimate,” and other similar or related expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond the Company's control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in the Company’s filings with the Securities and Exchange Commission. The Company undertakes no obligation to revise or update information in this release to reflect events or circumstances in the future, even if new information becomes available.

About Aeluma, Inc.

Aeluma (NASDAQ: ALMU) is a transformative semiconductor company specializing in high-performance photonic and electronic technologies that scale. The company’s proprietary platform combines compound semiconductors with scalable manufacturing used for mass market microelectronics to enable volume production and large-scale integration. Applications for Aeluma’s technology include mobile, AI, defense and aerospace, robotics, automotive, AR/VR, and quantum. Headquartered in Goleta, California, Aeluma operates state-of-the-art R&D and manufacturing capabilities for semiconductor wafer production, quick-turn chip fabrication, rapid prototyping, test and validation. Aeluma also partners with production-scale fabrication foundries, packaging, and integration companies. For more information, visit www.aeluma.com .

Company:

Aeluma, Inc.
(805) 351-2707
[email protected]

Investor Contact:

Financial Profiles, Inc.
Moira Conlon & Tony Rossi
(310) 622-8221
[email protected]

Aeluma, Inc. and Subsidiary
Consolidated Balance Sheets
($ in thousands) September 30,
2025
(unaudited) 		June 30,
2025
Assets
Current assets:
Cash and cash equivalents $ 25,920 $ 3,628
Certificate of deposit 12,227 12,112
Accounts receivable 1,248 962
Deferred compensation - -
Prepaids and other current assets 829 633
Total current assets 40,224 17,335
Property and equipment:
Equipment 1,902 1,692
Leasehold improvements 547 547
Accumulated depreciation (1,122 ) (1,021 )
Property and equipment, net 1,327 1,218
Right of use asset - operating 1,078 836
Other assets 24 17
Total assets $ 42,653 $ 19,406
Liabilities and stockholders' equity
Current liabilities:
Accounts payable $ 273 $ 361
Accrued expenses and other current liabilities 306 206
Lease liability - operating, current portion 189 138
Derivative liabilities - -
Total current liabilities 768 705
Lease liability - operating, long-term portion 992 803
Convertible notes - -
Total liabilities 1,760 1,508
Commitments and contingencies - -
Stockholders’ equity:
Preferred stock - -
Common stock 2 2
Additional paid-in capital 59,030 34,542
Accumulated deficit (18,139 ) (16,646 )
Total stockholders’ equity 40,893 17,898
Total liabilities and stockholders’ equity $ 42,653 $ 19,406



Aeluma, Inc. and Subsidiary
Consolidated Statements of Operations (unaudited)
Three Months Ended
($ in thousands, except per share data) September 30,
2025 		June 30,
2025 		September 30,
2024
Revenue $ 1,385 $ 1,317 $ 481
Operating expenses:
Cost of revenue 701 779 315
Research and development 606 165 401
General and administrative 1,686 1,342 496
Total operating expenses 2,993 2,286 1,212
Loss from operations (1,608 ) (969 ) (731 )
Other income (expense):
Interest income 115 110 -
Amortization of discount on convertible notes - - (145 )
Changes in fair value of derivative liabilities - - 146
Total other income, net 115 110 1
Loss before income tax expense (1,493 ) (859 ) (730 )
Income tax expense - - -
Net loss $ (1,493 ) $ (859 ) $ (730 )
Net loss per share – basic and diluted $ (0.09 ) $ (0.05 ) $ (0.06 )
Weighted average common shares outstanding – basic and diluted 16,141,153 15,824,222 12,178,424
Book value per share $ 2.53 $ 1.13 $ 0.14


Aeluma, Inc. and Subsidiary
Reconciliation of GAAP and Non-GAAP Financial Measures (unaudited)
Three Months Ended
($ in thousands, except per share data) September 30,
2025 		June 30,
2025 		September 30,
2024
GAAP net loss $ (1,493 ) $ (859 ) $ (730 )
Non-GAAP adjustments:
Stock-based compensation 1,056 744 167
Consulting and advisory - restricted stock award - 3 7
Amortization of discount on convertible notes - - 145
Changes in fair value of derivative liabilities - - (146 )
Total adjustments to GAAP net loss 1,056 747 173
Non-GAAP net loss $ (437 ) $ (112 ) $ (557 )
Depreciation & amortization 102 109 100
Interest income (115 ) (110 ) -
Adjusted EBITDA $ (450 ) $ (113 ) $ (457 )
GAAP net loss per share – basic and diluted $ (0.09 ) $ (0.05 ) $ (0.06 )
Non-GAAP adjustments 0.06 0.04 0.02
Non-GAAP net loss per share – basic and diluted $ (0.03 ) $ (0.01 ) $ (0.04 )



Aeluma, Inc. and Subsidiary
Consolidated Statements of Cash Flows (unaudited)
Three Months Ended
September 30,
($ in thousands) 2025 2024
Operating activities:
Net loss $ (1,493 ) $ (730 )
Adjustments to reconcile net loss to net cash used in operating activities:
Amortization of deferred compensation - 7
Stock-based compensation expense 1,056 167
Depreciation and amortization expense 102 100
Amortization of discount on convertible notes - 145
Changes in fair value of derivative liabilities - (146 )
Changes in operating assets and liabilities:
Accounts receivable (286 ) (262 )
Prepaids and other current assets (196 ) (167 )
Other assets (8 ) -
Accounts payable (88 ) (79 )
Accrued expenses and other current liabilities 98 34
Net cash used in operating activities (815 ) (931 )
Investing activities:
Purchase of equipment (210 ) (2 )
Net cash used in investing activities (210 ) (2 )
Financing activities:
Proceeds from stock option exercise 47 -
Proceeds from convertible notes issuance - 3,145
Proceeds from public offering, net of offering costs 23,385 -
Net cash provided by financing activities 23,432 3,145
Net change in cash and cash equivalents, and certificate of deposit 22,407 2,212
Cash and cash equivalents, and certificate of deposit, beginning of period 15,740 1,291
Cash and cash equivalents, and certificate of deposit, end of period $ 38,147 $ 3,503
Supplemental non-cash disclosures:
Right of use asset - operating obtained in exchange for lease liability - operating $ 274 -